TITAN PHARMACEUTICAL (TTP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (304)	10/17/2005 5:38:44 PM
From: Icebrg	Read Replies (2) of 362

And even more insider activity. Robert Farrel CFO has bought 24.000 shares at prices between 1,64 and 1,70. After these transactions he holds 71.780 shares. This is starting to look like a pattern. Erik Robert E. Farrell, J.D. – Executive Vice President and Chief Financial Officer Robert E. Farrell joined Titan as Executive Vice President and CFO in September 1996. Previously, Mr. Farrell was employed by Fresenius USA, Inc., a manufacturer and distributor of medical products and systems for the treatment of kidney failure, where he served as Vice President of Administration, CFO and General Counsel. His most recent position was Corporate Group Vice President. Mr. Farrell holds a J.D. from Hastings College of Law at the University of California and a B.A. from the University of Notre Dame.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next